Commercialisation of genetically modified poses significant risks and uncertainties – CCCFS warns

The Centre for Climate Change and Food Security (CCCFS) has expressed its opposition to the decision by the Ghana National Biosafety Authority (NBA) to approve the commercialisation of 14 novel genetically modified (GM) products, comprising eight maize and six soybean products.

In a press release from CCCFS, it said while it recognises the potential of biotechnology to address certain agricultural challenges, it firmly believes that the commercialisation of GM products poses significant risks and uncertainties that cannot be overlooked.

The Centre argued that “these risks extend beyond concerns about human health and environmental impact to encompass broader socio-economic implications.”

CCCFS in its press release on the matter has called for greater caution and prudence in the adoption of GM technology while urging government and regulatory authorities to prioritize the precautionary principle and exercise due diligence in evaluating the risks and benefits associated with GM products.

“CCCFS stands firmly opposed to the approval of GM products by the NBA. We remain committed to advocating for sustainable agricultural practices that promote resilience, equity, and the well-being of both present and future generations,” the press release by CCCFS signed by its Director of Research, Sulemana Issifu said.